The Impact of Age on Adaptive Immunity in Adults Infected With Respiratory Syncytial Virus — INFLAMMAGE  

RSV Infection Clinical Trial

Official title: The Impact of Age on Adaptive Immunity in Adults Infected With Respiratory Syncytial Virus

Status Recruiting

Clinical Trial Summary

This study will for the first time systematically investigate the immune responses in an elderly cohort challenged with a well-defined RSV inoculum. With a global aging population and continuing difficulties in generating vaccines that can reliably induce protective immunity in the elderly, these data will indicate the targets at which development of vaccines against RSV and other infections should be directed.

Clinical Trial Description

Respiratory syncytial virus (RSV) is one of the most common causes of chest infection worldwide, with 64 million episodes and 160,000 deaths each year. Despite this, it remains an underappreciated health problem and there are currently no specific treatments or vaccines against it. Although RSV infection is most frequent in young children, the majority of deaths occur in older adults, particularly in those with underlying heart and lung disease. This is believed to be due in part to the ageing immune system's reduced ability to protect against infection and symptomatic disease. However, little is known about the way human immune responses to RSV infection in older individuals differ from those of younger people. Further understanding of the mechanisms underlying immunity and potential impairments in these higher-risk people are therefore necessary. This project aims to study the role of T cells (which destroy virus-infected cells and are likely to be essential for recovery from infection) in healthy older volunteers after they have been given an RSV-induced common cold. Samples will be taken from the blood and respiratory tract in order to identify the differences in T cell responses that occur in older adults compared with their younger counterparts. Participants will be carefully screened to ensure they do not have any underlying health problems that might make them more at risk of severe disease and will be monitored closely throughout the course of infection. The investigators anticipate that T cell function even in healthy older individuals will be impaired compared to young adults, thus contributing in those with additional health problems to more severe disease. By analysing the networks of genes that are switched on and off, the investigators aim to identify the particular defects underlying these functional defects in order to ultimately define targets for novel treatments and T cell-stimulating vaccines. ;

Related Conditions & MeSH terms

• Infection
• Respiratory Syncytial Virus Infections
• RSV Infection

• NCT number: NCT03728413
• Study type: Interventional
• Source: Imperial College London
• Contact: Christopher Chiu, MRCP FRCPath PhD
• Phone: +442083832301
• Email: c.chiu@imperial.ac.uk
• Status: Recruiting
• Phase: N/A
• Start date: March 5, 2019
• Completion date: September 28, 2024